127 related articles for article (PubMed ID: 8613131)
41. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E;
Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990
[TBL] [Abstract][Full Text] [Related]
42. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
43. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
44. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
[TBL] [Abstract][Full Text] [Related]
45. Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.
Sung HJ; Kim SJ; Seo HY; Sul HR; Choi JG; Choi IK; Park KH; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Br J Haematol; 2006 Jul; 134(1):45-53. PubMed ID: 16803566
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
Yeh KH; Cheng AL; Su IJ; Lin MT; Tien HF; Shen MC; Wang CH; Chen YC
Anticancer Res; 1997; 17(3C):2269-72. PubMed ID: 9216700
[TBL] [Abstract][Full Text] [Related]
47. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
[TBL] [Abstract][Full Text] [Related]
48. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
49. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
50. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
[TBL] [Abstract][Full Text] [Related]
51. Direct comparison of peripheral T-cell lymphomas with their B-cell counterpart.
Liang R; Chiu E; Chan TK; Todd D; Loke SL
Acta Haematol; 1991; 85(4):179-83. PubMed ID: 1713011
[TBL] [Abstract][Full Text] [Related]
52. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).
Coiffier B; Brousse N; Peuchmaur M; Berger F; Gisselbrecht C; Bryon PA; Diebold J
Ann Oncol; 1990; 1(1):45-50. PubMed ID: 1706610
[TBL] [Abstract][Full Text] [Related]
53. Clinical roundtable monograph. T-cell lymphoma: therapeutic overview and disease state awareness.
Armitage JO; Hsi ED; Foss FM
Clin Adv Hematol Oncol; 2010 Dec; 8(12 Suppl 22):1-15. PubMed ID: 21491667
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.
Melnyk A; Rodriguez A; Pugh WC; Cabannillas F
Blood; 1997 Jun; 89(12):4514-20. PubMed ID: 9192775
[TBL] [Abstract][Full Text] [Related]
55. [Treatment of infantile non-Hodgkin's lymphoma].
Bernacer Borja M
An Esp Pediatr; 1990 Nov; 33 Suppl 43():149-54. PubMed ID: 2103986
[No Abstract] [Full Text] [Related]
56. Non-Hodgkin's lymphomas of Waldeyer's ring.
Jurga L; Vladimír A; Kulíková M; Klimo J; Berc A
Neoplasma; 1985; 32(6):729-35. PubMed ID: 4088392
[TBL] [Abstract][Full Text] [Related]
57. [Malignant lymphomas of the vulva and vagina].
Chalubinski K; Breitenecker G; Tatra G
Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):630-1. PubMed ID: 1294440
[TBL] [Abstract][Full Text] [Related]
58. T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease.
Bättig B; Mueller-Garamvoelgyi E; Cogliatti SB; Schmid U; Kappeler A; Cerny T; Laissue JA; Fey MF
Leuk Lymphoma; 1999 Apr; 33(3-4):393-8. PubMed ID: 10221522
[TBL] [Abstract][Full Text] [Related]
59. Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma.
Shimoyama M; Oyama A; Tajima K; Tobinai K; Minato K; Takenaka T; Konda C; Takeyama K; Kohno A; Narabayashi M
Leuk Lymphoma; 1993 Jul; 10(4-5):335-42. PubMed ID: 8220132
[TBL] [Abstract][Full Text] [Related]
60. [Pathological and clinical study of the primary B and T cell lymphomas of intestines].
Li GD
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):135-8. PubMed ID: 1477934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
